Impact of COVID-19 on Patients Hospitalized With Deep Vein Thrombosis and/or Pulmonary Embolism: A Nationwide Analysis

Hajra, Adrija; Goel, Akshay; Malik, Aaqib H; Isath, Ameesh; Shrivastav, Rishi; Gupta, Rahul; Das, Subrat; Krittanawong, Chayakrit; Bandyopadhyay, Dhrubajyoti

doi:10.1016/j.cpcardiol.2022.101553

Cited by 2 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 24 We discovered that 61% of patients with covid-19 infection who developed PE were at intermediate-high or high risk (37% and 24.1%, respectively). Our findings corroborated those of Hobohm et al, Miró et al, and Hajra et al 17 , 18 , 25 As we know, Patients who have COVID 19 infection make it difficult to do echocardiographic evaluations, necessitating special safety measures. 26 However, the most recent ESC recommendations suggested echocardiography as the primary imaging modality for early PE detection.…”

Section: Discussionsupporting

confidence: 91%

“…23 These results highlight the significance of clinical features, echocardiographic measures, computed tomography, and lab data for the diagnosis and prognostic classification of PE in COVID 19-infected patients. 24 We discovered that 61% of patients with covid-19 infection who developed PE were at intermediate-high or high risk (37% and 24.1%, 17,18,25 As we know, Patients who have COVID 19 infection make it difficult to do echocardiographic evaluations, necessitating special safety measures. 26 However, the most recent ESC recommendations suggested echocardiography as the primary imaging modality for early PE detection.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Patient Characteristics and Predictors of Pulmonary Embolism in Patients Infected with COVID – 19 in Upper Egypt

Hussein¹,

Khalaf²,

Alsharawy³

et al. 2023

VHRM

View full text Add to dashboard Cite

Background: A little is known about the risk factors and predictors of pulmonary embolism (PE) in Coronavirus disease 2019 infected patients. Therefore, we directed this study to investigate the predictors of PE in patients infected with Covid -19 in Upper Egypt. Methods: We conducted a retrospective cohort study on 297 patients infected with COVID-19, aged ≥ 18 years old. Suspicion of COVID-19 infection was based on the World Health Organization (WHO) criteria and confirmed by nasal and pharyngeal swab for real-time reverse transcriptase-polymerase chain reaction (RT-PCR) analysis. The patient was also determined to have COVID-19 when CT results that were thought to be typical for COVID-19 and clinical data that were compatible were present. Results: PE was diagnosed in 18.2% of patients. We found that the incidence of PE was significantly higher in older patients, females, those with higher BMI, hypertensive patients, diabetics, and patients with co-morbidities. Also, PE was significantly higher in patients presented with dyspnea, chest pain, longer duration of symptoms at hospital admission, and lower oxygen concentration. The mean serum Hb level, platelet count, TLC and absolute lymphocytic count were markedly reduced in those who had PE. All the patients who developed PE had a CO-RADS scale five on their CT chest scan. Age > 65, BMI > 25, DM, and associated co-morbidities were the independent patients' characteristics associated with the development of PE after the multivariate regression analysis. Conclusion: PE is a common complication of Covid 19 infection. PE is associated with a variety of clinical and laboratory parameters in univariate analysis, but age > 65, BMI > 25, DM, and associated co-morbidities were the independent patients' characteristics associated with the development of PE in those infected with Covid-19.

show abstract